Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06162572
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2023-11-29
Brief Title:
Phase 1b2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer NSCLC
Sponsor:
Servier Bio-Innovation LLC
Organization:
Servier
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-26
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-29
First Submit QC Date:
December 7 2023
Study First Post Date:
2023-12-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-01
Last Update Post Date:
2024-07-12
Last Update Post Date Type:
ACTUAL